New Methods of Endocrine Management of Prostatic Cancer
January 1987
in “
The Journal of urology/The journal of urology
”
TLDR New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.
The document reviewed new methods of endocrine management for prostatic cancer as of 1987. It discussed various hormonal therapies and their effectiveness in treating advanced stages of the disease. The review highlighted the use of nonsteroidal antiandrogens, luteinizing hormone-releasing hormone (LHRH) agonists, and other androgen withdrawal therapies. The findings suggested that these treatments could induce regression in prostate cancer, although long-term use might lead to testicular impairment. The review provided a comprehensive overview of the available endocrine treatment options and their potential impacts on patients.
